Join our Community
Support ToI and remove all ads
Learn more
×

immunotherapy

Dr. Nachum Nathan, left, and Prof. Ziv Shulman of Weizmann Institute of Science. (Courtesy)
May 26, 2026, 6:02 pm
In a world first, Israeli scientists find ‘memory’ B cells can target ovarian tumors
Immune cells not only remember viruses, but can also secrete tumor-fighting antibodies, say Weizmann Institute researchers; study could further development of cancer vaccines
By Diana Bletter
Prof. Ido Amit, left, Director of Weizmann’s Immunotherapy Research Center and PhD student Michelle von Locquenghien. (Courtesy)
November 20, 2025, 4:05 am
Scientists create ‘immune-activating’ molecule to help the body fight cancer
Using AI and big data, Weizmann Institute researchers build MiTEs, or natural killer/T-cell Enhancers, to combat cancers, 5 months after Iranian missile attack destroyed their lab
By Diana Bletter
PhD student Roni Hahn, left, and Prof. Karen Avraham, Dean the Gray Faculty of Medical & Health Sciences at Tel Aviv University. (Courtesy/Tel Aviv University)
September 24, 2025, 10:35 am
Israeli researchers report breakthrough gene therapy for hearing and balance disorders
Scientists from Tel Aviv University and Boston Children’s Hospital use an optimized virus to deliver a corrected gene into the patient’s cells, improving auditory and sensory loss
By Diana Bletter
Prof. Ayal Hendel, Bar Ilan University. Goodman Faculty of LIfe(Courtesy/Avishag Shaar-Yashuv)
September 2, 2025, 10:48 am
Israeli researcher joins EU cell therapy initiative for blood cancers and tumors
Bar-Ilan University scientist part of €8 million consortium to ensure accuracy in CAR-T cell therapy, an immunotherapy using CRISPR-Cas9, in European hospitals
By Diana Bletter
Weizmann Institute's Prof. Zelig Eshhar holds a board that illustrates how the cancer treatment works with mice, August 29, 2017. (Shoshanna Solomon/Times of Israel)
July 4, 2025, 1:15 pm
Zelig Eshhar, leading cancer researcher and immunologist, dies at 84
Research by Weizmann Institute scientist and Israel Prize winner saved ‘countless lives,’ was basis for technology sold for $12 billion in 2017
By ToI Staff
Ronen Bar, head of the Shin Bet security service, at a memorial service marking 27 years since the assassination of late Prime Minister Yitzhak Rabin, held at Mount Herzl cemetery in Jerusalem on November 6, 2022. (Olivier Fitoussi/Flash90)
June 12, 2023, 1:53 pm
Daily Briefing June 12: Is it safe to use the Shin Bet to fight Arab violent crime?
Editor David Horovitz on U-20 World Cup tourney, MK Yair Lapid’s testimony and new efforts to stop wave of killings; health reporter Renee Ghert-Zand on uptick of youth smoking
By ToI Staff
Israeli security forces demolish the house of Palestinian terrorist Eslam Froukh, in the West Bank city of Ramallah, June 8, 2023. (Flash90)
June 11, 2023, 1:04 pm
Daily Briefing Jun 11: In rare move, IDF enters Ramallah. Why is this significant?
Military correspondent Emanuel Fabian with Lebanon border riot and uptick of violence in Arab communities; news editor Amy Spiro with two new stranger-than-fiction nonfiction books
By ToI Staff
File: Heads of opposition parties Labor MK Merav Michaeli, Yesh Atid head MK Yair Lapid, National Unity head MK Benny Gantz, Israel Beteinu head MK Avigdor Liberman and leader of the United Arab List MK Mansour Abbas hold a joint press conference in Tel Aviv, on March 16, 2023. (Avshalom Sassoni/Flash90)
June 8, 2023, 1:17 pm
Daily Briefing June 8: Opposition unites on judicial panel pick, but does it matter?
Knesset correspondent Carrie Keller-Lynn on squabbling ahead of Judicial Selection Committee vote; health reporter Renee Ghert-Zand on whooping cough outbreak, 1st case of progeria
By ToI Staff
Illustrative image: A cancer patient receives immunotherapy (Elaine Thompson/AP Photo)
June 7, 2023, 1:03 pm
New Israeli technology improves prediction of patient response to immunotherapy
Ben-Gurion University researchers develop innovative biosensor, team up with Israeli biotech company OncoHost in bid for FDA approval
By Renee Ghert-Zand
Prime Minister Benjamin Netanyahu leads a meeting at the Prime Minister's Office in Jerusalem on January 3, 2023. (Yonatan Sindel/Flash90)
January 11, 2023, 1:20 pm
Daily Briefing Jan. 11: Will Netanyahu need to brush up on foreign diplomacy skills?
Diplomatic correspondent Lazar Berman discusses the premier and international critics; health writer Nathan Jeffay looks at COVID boosters, a soft drink backlash, and immunotherapy
By ToI Staff
An image from the Bar Ilan University lab of Prof. Cyrille Cohen, showing two immune cells in green fighting a cancer cell in red, in the new immunotherapy invented there (Cyrille Cohen, Tilda Barliya and Astar Shamul)
January 4, 2023, 4:55 pm
After demonstrating 57% remission rate, Israeli immunotherapy licensed by US firm
Some 85% of patients improved after taking new therapy developed by Bar Ilan and Hadassah; method involves adding artificial molecule to T-cells
By Nathan Jeffay
Medical Illustration of lung cancer, with a cancerous area in lungs (peterschreiber.media via iStock by Getty Images)
August 30, 2022, 10:08 pm
Lung fluid may provide basis for cancer-treating vaccines: Israeli research
Scientists say specific proteins found in lung fluid could theoretically be used to develop new methods for diagnosing and possibly treating cancer
By Nathan Jeffay
A computer-generated image of the synthetic cancer-fighting molecule developed at Tel Aviv University encountering proteins that inhibit the immune system. After encountering the proteins it reprograms them, to enable the immune system to fight the tumor. (courtesy of Tel Aviv University)
August 10, 2022, 11:52 am
Israeli scientists racing to deliver world’s 1st pill-form immunotherapy for cancer
Cancer patients currently need to visit a hospital for treatment; Israeli-Portuguese research could change this, scientists say, although potential drug years away
By Nathan Jeffay
Biomica's pills, which are starting clinical trial in Israel (courtesy of Biomica)
June 24, 2022, 7:54 pm
Israeli company to test if fecal bacteria pills boost cancer immunotherapy
Prospective medication seeks to tweak gut germs in patients who don’t respond well to treatment, utilizing research that suggests microbiome impacts effectiveness
By Nathan Jeffay
A doctor prepares a chemotherapy drug (iStock via Getty Images)
April 5, 2022, 12:17 pm
Israeli 2-in-1 cancer drug shows promise in boosting chemo and immunotherapy
Encouraging results seen in mice study for world’s first RNA-based drug of its kind; it helps chemotherapy attack tumors and assists immunotherapy in strengthening immune system
By Nathan Jeffay
Load More

Sign in or Join The Times of Israel Community

Sign in or Register

Paying ToI Community members are invited to comment on articles
Please use the following structure: example@domain.com
Or Continue with
By joining you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Join The Times of Israel Community
Sign in or Register
Only ToI Community members can comment below articles
Forgot your password? / Send me a login link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.
Back to top
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.